Evidence map›Paper›PMID 33918318›Full record

ReviewCells2021

The Transmission of SARS-CoV-2 Infection on the Ocular Surface and Prevention Strategies.

Koji Kitazawa, Stefanie Deinhardt-Emmer, Takenori Inomata, Sharvari Deshpande, Chie Sotozono

Open access · goldAbstract readReview
In one paragraph

Review in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Ocular manifestations in COVID-19 infections: a case series.Annals of medicine and surgery (2012) · 2023
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Ocular symptoms in COVID-19 infection: a survey study.Journal of ophthalmic inflammation and infection · 2022
    Article
  16. Current clinical status of new COVID-19 vaccines and immunotherapy.Environmental science and pollution research international · 2022
    Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 3 countries.

Koji KitazawaDepartment of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto 6020841, Japan.ORCID 0000-0003-2203-5776
Stefanie Deinhardt-EmmerBuck Institute for Research on Aging, Novato, CA 94945, USA.
Takenori InomataDepartment of Ophthalmology, Juntendo University Graduate School of Medicine, Tokyo 1138421, Japan.ORCID 0000-0003-3435-1055
Sharvari DeshpandeBuck Institute for Research on Aging, Novato, CA 94945, USA.
Chie SotozonoDepartment of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto 6020841, Japan.
Buck Institute for Research on Aging · USJuntendo University · JPKyoto Prefectural University of Medicine · JP

Funding

German Research Foundation NUM-COVID 19German Research Foundation Organo-Strat 01KX2021Japan Society for the Promotion of Science #201960725
6 · The paper itself

Abstract

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a global health problem. Although the respiratory system is the main impaired organ, conjunctivitis is one of its common findings. However, it is not yet understood if SARS-CoV-2 can infect the eye and if the ocular surface can be a potential route of SARS-CoV-2 transmissions. Our review focuses on the viral entry mechanisms to give a better understanding of the interaction between SARS-CoV-2 and the eye. We highlighted findings that give evidence for multiple potential receptors of SARS-CoV-2 on the ocular surface. Additionally, we focused on data concerning the detection of viral RNA and its spike protein in the various ocular tissues from patients. However, the expression level seemed to be relatively low compared to the respiratory tissues as a result of a unique environment surrounding the ocular surface and the innate immune response of SARS-CoV-2. Nevertheless, our review suggests the ocular surface as a potential route for SARS-CoV-2 transmission, and as a result of this study we strongly recommend the protection of the eyes for ophthalmologists and patients at risk.

Indexed as

Virus InternalizationCOVID-19EyeHost-Pathogen InteractionsHumansSARS-CoV-2ACE2COVID-19COVID conjunctivitisocular transmissionSARS-CoV-2virus entry

Identifiers

PMID33918318
PMCPMC8065845
OpenAlexW3149090665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.